Detalles de la búsqueda
1.
Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials.
Circulation;
149(11): 825-838, 2024 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38059368
2.
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial.
Circulation;
148(22): 1735-1745, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37632455
3.
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF.
Circulation;
147(22): 1670-1683, 2023 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37039015
4.
Wearable Sensors to Monitor Physical Activity in Heart Failure Clinical Trials: State-of-the-Art Review.
J Card Fail;
30(5): 703-716, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38452999
5.
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF.
J Card Fail;
30(1): 26-35, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37683911
6.
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
Eur Heart J;
44(24): 2170-2183, 2023 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37220172
7.
Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics.
Eur Heart J;
44(31): 2966-2977, 2023 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37210742
8.
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial.
Circulation;
145(3): 158-169, 2022 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34743554
9.
Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF.
Circulation;
146(6): 438-449, 2022 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35442064
10.
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF.
Circulation;
146(13): 980-994, 2022 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35971840
11.
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials.
Lancet;
400(10354): 757-767, 2022 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36041474
12.
Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials.
Diabetes Obes Metab;
25(11): 3327-3336, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37580309
13.
Preventing Recurrent Cardioembolic Stroke: Right Approach, Right Patient (PRECISE) Study Protocol.
Cerebrovasc Dis;
52(2): 123-129, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36037797
14.
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA-HF Trial.
Ann Intern Med;
175(6): 820-830, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35467935
15.
Accelerated and personalized therapy for heart failure with reduced ejection fraction.
Eur Heart J;
43(27): 2573-2587, 2022 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35467706
16.
Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction.
Circulation;
144(3): 199-209, 2021 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33983794
17.
Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF.
Circulation;
143(20): 1962-1972, 2021 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33832352
18.
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF.
Circulation;
143(4): 298-309, 2021 01 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33040613
19.
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).
Circulation;
143(6): 516-525, 2021 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33186500
20.
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
N Engl J Med;
381(21): 1995-2008, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31535829